La bourse ferme dans 3 h 29 min

Pediatrix Medical Group, Inc. (MD)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
19,90+0,03 (+0,15 %)
À la clôture : 04:00PM EDT
19,83 -0,07 (-0,35 %)
Échanges après Bourse : 05:23PM EDT

Pediatrix Medical Group, Inc.

1301 Concord Terrace
Sunrise, FL 33323
United States
954 384 0175
https://www.mednax.com

Secteur(s)Healthcare
Secteur d’activitéMedical Care Facilities
Employés à temps plein5 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Mark S. OrdanCEO & Director3,35M1,66M1959
Dr. Roger J. Medel M.D.Co-Founder & Director50,99kS.O.1947
Mr. C. Marc RichardsExec. VP & CFO1,29MS.O.1971
Mr. John C. PepiaSr. VP & Chief Accounting Officer931,2kS.O.1963
Mr. Dominic J. AndreanoExec. VP, Gen. Counsel & Sec.1,29MS.O.1969
Ms. Mary Ann E. MooreExec. VP and Chief Enterprise Risk & Legal Operations Officer3,21MS.O.1960
Dr. James D. Swift M.D.Exec. VP & Chief Operating OfficerS.O.S.O.S.O.
Ms. Cheryl M. VanPattanSr. VP & Chief Information OfficerS.O.S.O.S.O.
Mr. Charles W. Lynch C.F.A.Sr. VP of Fin., Strategy & Investor RelationsS.O.S.O.S.O.
Ms. Dana Dreher-RodwellVP & Chief Compliance OfficerS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2021 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Pediatrix Medical Group, Inc. en date du 31 juillet 2022 est 3. Les scores principaux sont Audit : 4; Société : 3; Droits des actionnaires : 2; Compensation : 7.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.